Navigation Links
New DNA-Based Blood Test May Spot Signs of Cancer
Date:11/28/2012

By Randy Dotinga
HealthDay Reporter

WEDNESDAY, Nov. 28 (HealthDay News) -- A new study raises the possibility of a DNA-based blood test that doctors could routinely use to determine whether a patient has cancer.

There are many caveats. The research is preliminary, and the test is not cheap. Even if it does detect cancer, the test -- like the one currently used to detect prostate cancer -- could raise big questions about how to deal with the results.

Even so, a genetic test for cancer would be a major advance, experts say.

"This would be a way of detecting cancers earlier, and to tell you the level of cancer as you're going through the therapy," said Dr. Victor Velculescu, co-director of the Cancer Biology Program at Johns Hopkins Kimmel Cancer Center in Baltimore.

Several blood tests detect the body's reaction to cancer, and others are being developed, including one that may spot stray cancer cells in the blood. This test is unique because it examines the blood for signs of DNA that's spilled out of cancerous cells into the bloodstream when they die, Velculescu explained.

In the study, researchers found that the test picked up differences in 10 patients with breast or colorectal cancer when compared to 10 healthy patients. The test didn't falsely suggest any of the healthy patients had cancer, he added.

"We're looking at the entire genome and can apply the test to any cancer type or individual cancer," Velculescu said.

The test costs hundreds of thousands of dollars, but Velculescu expects the price would eventually drop.

In the future, he said, the test could be performed at regular intervals and detect cancer without requiring a biopsy. For now, however, the test needs to undergo more research.

There's one possible complication: If the test detects signs of cancer, then what? A blood screening test for prostate cancer, known as the PSA test, is a topic of hot debate because some patients may undergo unnecessary treatment.

Still, Dr. Otis Brawley, chief medical officer and executive vice president of the American Cancer Society, said he can foresee a cancer screening blood test becoming a routine part of medicine, although it may take 20 years or more to get there.

In some cases, Brawley said, doctors could potentially choose to use the screening test to evaluate the extent of cancer in a patient instead of performing a biopsy. For example, in certain types of lung cancer, a biopsy can be dangerous because a needle is inserted into the lung, he noted.

For now, Brawley said, the test is "extremely expensive and extremely preliminary, and it's probably several years before anybody's going to be able to buy this."

The study appears in the Nov. 28 issue of the journal Science Translational Medicine.

More information

For more about cancer, visit the U.S. National Library of Medicine.

SOURCES: Victor Velculescu, M.D., Ph.D., associate professor, oncology, and co-director, Cancer Biology Program, Kimmel Cancer Center, Johns Hopkins University, Baltimore; Otis Brawley, M.D., chief medical officer and executive vice president, American Cancer Society, Atlanta; Nov. 28, 2012, Science Translational Medicine


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Johns Hopkins scientists pair blood test and gene sequencing to detect cancer
2. High Blood Pressure During Pregnancy Tied to Later Heart Trouble
3. Impaired blood vessel function found in cystic fibrosis patients
4. Pathway identified in human lymphoma points way to new blood cancer treatments
5. Genetic factor holds key to blood vessel health
6. Exercise benefits found for pregnancies with high blood pressure
7. Human umbilical cord blood cell co-culture supports embryonic stem cell expansion
8. G proteins regulate remodelling of blood vessels
9. No Need to Fast Before Cholesterol Blood Test: Study
10. Drinking green tea with starchy food may help lower blood sugar spikes
11. Diabetes study: Mindful eating equals traditional education in lowering weight and blood sugar
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New DNA-Based Blood Test May Spot Signs of Cancer
(Date:10/13/2017)... ... ... The American Board of Family Medicine's (ABFM) Board of Directors has selected ... Dr. James C. Puffer upon his retirement. Dr. Newton will serve in the position ... the end of 2018. Upon assuming the role of President and CEO on January ...
(Date:10/13/2017)... ... , ... Apple Rehab Shelton Lakes , which specializes in the delivery ... as part of a disaster drill on October 3rd. , Apple Rehab participated with ... Manager, as well as the Connecticut Long Term Care Mutual Aid Plan (LTC-MAP). ...
(Date:10/13/2017)... ... 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of ... popular and least understood books in the Holy Scriptures, Revelation. The Book of Revelation ... scholars for centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... advisory services for healthcare compliance program management, will showcase a range of technology ... Association for Assisted Living (NCAL) Convention and Expo to be held October 14–18, ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical Informatics (ACMI) will ... during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual ... F. Collen, a pioneer in the field of medical informatics, this prestigious award is ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... IRVING, Texas , Oct. 11, 2017  Caris ... science focused on fulfilling the promise of precision medicine, ... Institute has joined Caris, Precision Oncology Alliance™ (POA) as ... leading cancer centers, the St. Jude Crosson Cancer Institute ... to advance the use of tumor profiling, making cancer ...
(Date:10/11/2017)... , Oct. 11, 2017  Hill-Rom Holdings, Inc. ... Aspen Surgical facility in Las Piedras, Puerto ... scalpels and blades. ... that the facility sustained minor structural damage, temporary loss ... Maria. Repairs have been completed, manufacturing operations have resumed, ...
(Date:10/10/2017)... 2017   West Pharmaceutical Services, Inc. (NYSE: ... drug administration, today shared the results of a study ... the intradermal administration of polio vaccines. The study results ... May 2017 by Dr. Ondrej Mach , Clinical ... Organization (WHO), and recently published in the journal ...
Breaking Medicine Technology: